Drug intelligence / Profile preview

Sporlac

Development stage
Unknown
Lead developer
Sanzyme
Modality
Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Sporlac is an Indian probiotic brand containing spores of lactic acid–producing bacteria, historically referred to as lactic acid bacillus or Lactobacillus sporogenes and now taxonomically classified as Bacillus coagulans, used primarily to restore and maintain healthy intestinal microflora in diarrheal and other gastrointestinal disorders.[10][12] The spore-forming Bacillus coagulans strain (e.g., SNZ1969 in Sporlac-branded products) survives gastric acidity, germinates in the small intestine, and produces lactic acid and other antimicrobial substances that inhibit pathogenic organisms, support recolonization with beneficial flora, and modulate local gut immunity.[2][10][12] Clinically, Sporlac and its high-strength variants (such as Sporlac DS) are widely prescribed in India, especially in pediatrics, as adjunctive therapy for acute and antibiotic-associated diarrhea, gastroenteritis, colitis, and functional gastrointestinal complaints like bloating and indigestion.[10][12]

Brand names
Sporlac

Beyond the preview

Go deeper on Sporlac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sporlac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call